Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Absci (Nasdaq: ABSI) will participate in the 25th Annual Needham Virtual Healthcare Conference.

Management is scheduled for a fireside chat on April 16, 2026 at 1:30 p.m. ET (10:30 a.m. PT). A live and archived webcast will be available on the company's investor relations website.

News Market Reaction – ABSI

+2.40%

+2.40% Session close to close

In the Apr 8 session, ABSI gained 2.40%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Absci’s participation in a high-profile healthcare conference, offering...

Analysis

This announcement highlights Absci’s participation in a high-profile healthcare conference, offering a platform to communicate its AI-driven pipeline and ABS-201 progress to investors. In recent months, the company reported a full-year 2025 net loss of $115.2 million with cash of $144.3 million and filed a preliminary $400,000,000 shelf registration, underscoring ongoing funding needs. Investors following this update may watch for any new clinical, partnership, or capital-raising details emerging from related presentations or Q&A sessions.

Key Figures

Conference edition: 25th Annual Fireside chat time: 1:30 p.m. ET

2 metrics

Conference edition 25th Annual Needham Virtual Healthcare Conference

Fireside chat time 1:30 p.m. ET Scheduled on Thursday, April 16th

Historical Context

5 past events · Latest: Mar 24 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Mar 24	Earnings & update	Neutral	-3.0%	Q4 and 2025 results plus ABS-201 safety and cash runway update.
Mar 24	Clinical strategy	Positive	+2.7%	Endometriosis Advisory Board formed to guide ABS-201 Phase 2 plans.
Mar 06	Equity inducement	Neutral	+5.5%	Inducement stock option grant to new Chief Medical Officer.
Mar 03	Leadership change	Positive	-8.2%	New CMO appointed and Chief Innovation Officer transition announced.
Feb 24	Earnings date set	Neutral	+2.3%	Announcement of timing for Q4 and full-year 2025 results call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news shows mixed alignment: clinical and strategic updates often see positive or modestly positive reactions, while leadership or governance changes have occasionally coincided with notable downside.

Recent Company History

Over the last several weeks, Absci has focused on advancing its AI-designed pipeline and strengthening leadership. Earnings and 10-K disclosures on March 24, 2026 highlighted ABS-201 progress and cash of $144.3M, but the stock fell 2.99%. Launch of an ABS-201 Endometriosis Advisory Board on March 24 saw a 2.73% gain, while appointment of a new CMO on March 3 coincided with an 8.21% decline. Today’s conference participation fits the pattern of routine investor-relations updates, akin to prior earnings-date and governance communications.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

VANCOUVER, Wash. and NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the upcoming 25^th Annual Needham Virtual Healthcare Conference.

Absci management is scheduled to participate in a fireside chat on Thursday, April 16^th at 1:30 p.m. Eastern Time (10:30 a.m. Pacific Time). Interested parties may access a live and archived webcast on the company’s investor relations website at: investors.absci.com.

About Absci

Absci is advancing the future of drug discovery with generative design to create better biologics for patients, faster. Our Integrated Drug Creation™ platform combines cutting-edge AI models with a synthetic biology data engine, enabling the rapid design of innovative therapeutics that address challenging therapeutic targets. Absci’s approach leverages a continuous feedback loop between advanced AI algorithms and wet lab validation. Each cycle refines our data and strengthens our models, facilitating rapid innovation and enhancing the precision of our therapeutic designs. Alongside collaborations with top pharmaceutical, biotech, tech, and academic leaders, Absci is advancing its own pipeline of AI designed therapeutics including ABS-201™, a groundbreaking innovation in hair regrowth with the potential to redefine treatment possibilities for androgenetic alopecia, commonly known as male and female pattern hair-loss. ABS-201 is also being investigated as a potential “best-in-class” therapeutic for endometriosis, a condition with significant unmet medical need and market potential. Absci is headquartered in Vancouver, WA, with AI Research Labs in New York City and Serbia, and an Innovation Center in Switzerland. Learn more at www.absci.com or follow us on LinkedIn (@absci), X (@Abscibio) and YouTube.

Absci^® standard character mark, ABS-201™, and Integrated Drug Creation™ are trademarks and registered trademarks of Absci Corporation.

Investor Contact
Alexander D.H. Khan
Corporate Vice President
Head of Investor Relations
investors@absci.com

Media Contact
press@absci.com

FAQ

When will Absci (ABSI) present at the Needham Virtual Healthcare Conference in April 2026?

Absci will present on April 16, 2026 at 1:30 p.m. Eastern Time. According to the company, management will take part in a fireside chat and the session will be webcast live and archived on the investor relations site.

How can investors watch Absci's (ABSI) Needham Conference presentation on April 16, 2026?

Investors can watch via a live and archived webcast on Absci's investor relations website. According to the company, the webcast will be accessible at investors.absci.com for both live viewing and later replay.

What will Absci (ABSI) management do at the 25th Annual Needham Virtual Healthcare Conference?

Management will participate in a fireside chat focused on the company's progress and outlook. According to the company, the session offers investor access to management commentary and will be available by webcast.

What time is Absci's (ABSI) fireside chat for Pacific Time on April 16, 2026?

The fireside chat is scheduled for 10:30 a.m. Pacific Time on April 16, 2026. According to the company, the event is listed as 1:30 p.m. Eastern Time and will be webcast for remote viewers.

Where will the archived recording of Absci's (ABSI) Needham presentation be hosted after April 16, 2026?

The archived recording will be hosted on Absci's investor relations website. According to the company, attendees and investors can access the replay at investors.absci.com following the live webcast.